Therapixel

Therapixel is a private, commercial-stage French medtech company focused on AI for radiology. It has successfully transitioned from its origins in surgical imaging software to become a pure-play radiology AI developer, with MammoScreen as its cornerstone product. The company has achieved significant commercial validation, including a partnership with Mayo Clinic and a national deployment deal with Onsite Women's Health. Its strategy is centered on leveraging its award-winning AI algorithms to improve the accuracy and efficiency of breast cancer screening.

AI and computer vision platform for analyzing medical images, specializing in deep learning algorithms for mammogram interpretation. The platform was proven by winning the 2017 DREAM Digital Mammography Challenge.

Therapixel operates in the highly competitive AI radiology software market, competing directly with companies like iCAD, Hologic, ScreenPoint Medical, and numerous other startups. Its differentiation is based on its award-winning algorithm performance and strategic commercial partnerships with major healthcare providers.